Document2009.-Weighing Benefits and Risks the FDA's Review of Prasugrelîncărcat de
tristan9454- Document2009.Prasugrel in Clinical Practice..încărcat detristan9454
- Document2009.-Prasugrel in Clinical Practiceîncărcat detristan9454
- Document2009.- Weighing Benfits and Risk...încărcat detristan9454
- Document2009.- Prasugrel Stemi Subgroup Analysis.autor's Replyîncărcat detristan9454
- Document2009.- Prasugrel Stemi Subgroup Analysisîncărcat detristan9454
- Document2009.- Effect of the Novel Thienopyridine Prasugrel....încărcat detristan9454
- Document2008.-The Use of the VerifyNow P2Y12 Point-Of-care Device to Monitorîncărcat detristan9454
- Document2008.Prasugrel...Acute Coronary Syndromesîncărcat detristan9454
- Document2008.-Prasugrel Achieves Greater and Faster P2Y12..încărcat detristan9454
- Document2008.-Bleeding Risks With Pasugre.....încărcat detristan9454
- Document2008. Prasugrel.....Patients With Acute Coronary.încărcat detristan9454
- Document2008. Intensive Anti Platelet ... Prasugrelîncărcat detristan9454
- Document2007.-A Comparison of the Anti Platelet Effects of Prasugrel..încărcat detristan9454
- Document2009.- Stroke Prevention in Atrial Fibrillation....încărcat detristan9454
- Document2009.- Cutaneous Blodd Filled Vesicles on Idraparinuxîncărcat detristan9454
- Document2009.- Comparison of Idraparinux With Vitamin Kîncărcat detristan9454
- Document2007.-High Affinity Interaction Between a Synthetic, Highly Negatively Charged..încărcat detristan9454
- Document2007.-Agents to Control Bleeding Show Promiseîncărcat detristan9454
- Document2005.-Reversal of a Potent Investigational Anticoagulant Idraparinux With Recombinant Factor VIIa.încărcat detristan9454
- Document2005.Reversal Investigational Anticoagulan Idraparinux...încărcat detristan9454
- Document2004.Oligosaccharides...încărcat detristan9454
- Document2003.Synthetic Pentasaccharides...încărcat detristan9454
- DocumentShort- And Long-Acting Synthetic Pent a Sac Char Idesîncărcat detristan9454
- Document2009.- The Pharmacokinetics of Idraparinux, A Long-Acting Indirect Factor Xa Inhibitor Population Pharmacokinetic Analysis From Phase III Clinical Trials.încărcat detristan9454
- Document2006.-Thrombocytopenia Associated With the Use ...încărcat detristan9454
- Document2006.-Frequency and Management of Thrombocytopenia...încărcat detristan9454
- Document2006.-Abciximab Associated Thrombocytopenia...încărcat detristan9454
- Document2005.-Immune Thrombocytopenia Caused by Glycoprotein....încărcat detristan9454
- Document2004.-Repetitive Profound Thrombocytopenia After Treatment With Tirofiban a Case Report.încărcat detristan9454
- Document2009.-First Report of Tirofiban-Induced Anemia (Found in Combination With Severe Thrombocytopeniaîncărcat detristan9454
- Document2002.-Acute Thrombocytopenia After Treatment With Tirofiban or Eptifibatide is a2002.încărcat detristan9454
- Document2006.-Thrombocytopenia Associated With the Use ...încărcat detristan9454
- Document2006.-Frequency and Management of Thrombocytopenia...încărcat detristan9454
- Document2006.-Abciximab Associated Thrombocytopenia...încărcat detristan9454
- Document2005.-Immune Thrombocytopenia Caused by Glycoprotein....încărcat detristan9454
- Document2004.-Repetitive Profound Thrombocytopenia After Treatment With Tirofiban a Case Report.încărcat detristan9454
- Document2002.-Acute Thrombocytopenia After Treatment With Tirofiban or Eptifibatide is a2002.încărcat detristan9454
- Document2009.-First Report of Tirofiban-Induced Anemia (Found in Combination With Severe Thrombocytopeniaîncărcat detristan9454
- Document1.-BISTRO Iîncărcat detristan9454
- Document1.-BISTRO Iîncărcat detristan9454
Documente Academic
Documente Profesional
Documente Cultură
